25
Participants
Start Date
November 8, 2021
Primary Completion Date
December 5, 2023
Study Completion Date
December 5, 2023
LBL-015 for Injections
Initial dose - MTD ; Q2W ; intravenous infusion
Shanghai East Hospital, Shanghai
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Shandong Cancer Hospital, Jinan
The First Affiliated Hospital of Nanchang University, Nanchang
Hunan Cancer Hospital, Changsha
Henan Cancer Hospital, Zhengzhou
Shanghai East Hospital
OTHER
Shandong Cancer Hospital and Institute
OTHER
Henan Cancer Hospital
OTHER_GOV
Hunan Cancer Hospital
OTHER
The First Affiliated Hospital of Nanchang University
OTHER
The First Affiliated Hospital of Bengbu Medical University
OTHER
Nanjing Leads Biolabs Co.,Ltd
INDUSTRY